FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3140444220> ?p ?o ?g. }

• W3140444220 endingPage "587" @default.
• W3140444220 startingPage "575" @default.
• W3140444220 abstract "Renin-angiotensin system (RAS) inhibitors reduce cardiovascular morbidity and mortality in patients with CKD. We evaluated the cardioprotective effects of the angiotensin-converting enzyme inhibitor ramipril in patients on maintenance hemodialysis.In this phase 3, prospective, randomized, open-label, blinded end point, parallel, multicenter trial, we recruited patients on maintenance hemodialysis with hypertension and/or left ventricular hypertrophy from 28 Italian centers. Between July 2009 and February 2014, 140 participants were randomized to ramipril (1.25-10 mg/d) and 129 participants were allocated to non-RAS inhibition therapy, both titrated up to the maximally tolerated dose to achieve predefined target BP values. The primary efficacy end point was a composite of cardiovascular death, myocardial infarction, or stroke. Secondary end points included the single components of the primary end point, new-onset or recurrence of atrial fibrillation, hospitalizations for symptomatic fluid overload, thrombosis or stenosis of the arteriovenous fistula, and changes in cardiac mass index. All outcomes were evaluated up to 42 months after randomization.At comparable BP control, 23 participants on ramipril (16%) and 24 on non-RAS inhibitor therapy (19%) reached the primary composite end point (hazard ratio, 0.93; 95% confidence interval, 0.52 to 1.64; P=0.80). Ramipril reduced cardiac mass index at 1 year of follow-up (between-group difference in change from baseline: -16.3 g/m2; 95% confidence interval, -29.4 to -3.1), but did not significantly affect the other secondary outcomes. Hypotensive episodes were more frequent in participants allocated to ramipril than controls (41% versus 12%). Twenty participants on ramipril and nine controls developed cancer, including six gastrointestinal malignancies on ramipril (four were fatal), compared with none in controls.Ramipril did not reduce the risk of major cardiovascular events in patients on maintenance hemodialysis.ARCADIA, NCT00985322 and European Union Drug Regulating Authorities Clinical Trials Database number 2008-003529-17." @default.
• W3140444220 created "2021-04-13" @default.
• W3140444220 creator A5000643733 @default.
• W3140444220 creator A5002432559 @default.
• W3140444220 creator A5007108229 @default.
• W3140444220 creator A5010478903 @default.
• W3140444220 creator A5019186356 @default.
• W3140444220 creator A5023335599 @default.
• W3140444220 creator A5024161204 @default.
• W3140444220 creator A5026503523 @default.
• W3140444220 creator A5029489154 @default.
• W3140444220 creator A5036626021 @default.
• W3140444220 creator A5038498390 @default.
• W3140444220 creator A5039171721 @default.
• W3140444220 creator A5042841176 @default.
• W3140444220 creator A5043591172 @default.
• W3140444220 creator A5046728362 @default.
• W3140444220 creator A5048679120 @default.
• W3140444220 creator A5052434587 @default.
• W3140444220 creator A5054235531 @default.
• W3140444220 creator A5059170624 @default.
• W3140444220 creator A5059276594 @default.
• W3140444220 creator A5063740495 @default.
• W3140444220 creator A5064584522 @default.
• W3140444220 creator A5065969947 @default.
• W3140444220 creator A5072076748 @default.
• W3140444220 creator A5074897413 @default.
• W3140444220 creator A5076316519 @default.
• W3140444220 creator A5077169554 @default.
• W3140444220 creator A5078207874 @default.
• W3140444220 creator A5080835829 @default.
• W3140444220 creator A5081063920 @default.
• W3140444220 creator A5086608494 @default.
• W3140444220 creator A5087811410 @default.
• W3140444220 creator A5089585668 @default.
• W3140444220 creator A5090926666 @default.
• W3140444220 date "2021-03-29" @default.
• W3140444220 modified "2023-10-18" @default.
• W3140444220 title "Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis" @default.
• W3140444220 cites W1581746603 @default.
• W3140444220 cites W1870222753 @default.
• W3140444220 cites W1911188572 @default.
• W3140444220 cites W1981387399 @default.
• W3140444220 cites W1999385443 @default.
• W3140444220 cites W2000968765 @default.
• W3140444220 cites W2023755744 @default.
• W3140444220 cites W2044815620 @default.
• W3140444220 cites W2051249163 @default.
• W3140444220 cites W2055123579 @default.
• W3140444220 cites W2063018186 @default.
• W3140444220 cites W2063880582 @default.
• W3140444220 cites W2075976485 @default.
• W3140444220 cites W2078142203 @default.
• W3140444220 cites W2090131666 @default.
• W3140444220 cites W2106584637 @default.
• W3140444220 cites W2107009419 @default.
• W3140444220 cites W2110601215 @default.
• W3140444220 cites W2116047979 @default.
• W3140444220 cites W2116341826 @default.
• W3140444220 cites W2124761610 @default.
• W3140444220 cites W2124764590 @default.
• W3140444220 cites W2126000729 @default.
• W3140444220 cites W2133132829 @default.
• W3140444220 cites W2133217116 @default.
• W3140444220 cites W2135658710 @default.
• W3140444220 cites W2142692547 @default.
• W3140444220 cites W2145632027 @default.
• W3140444220 cites W2157192902 @default.
• W3140444220 cites W2159559723 @default.
• W3140444220 cites W2161832913 @default.
• W3140444220 cites W2162199393 @default.
• W3140444220 cites W2165141146 @default.
• W3140444220 cites W2318994121 @default.
• W3140444220 cites W2607253611 @default.
• W3140444220 cites W2614763070 @default.
• W3140444220 cites W2801783846 @default.
• W3140444220 cites W2808650372 @default.
• W3140444220 cites W2895759303 @default.
• W3140444220 cites W2918092070 @default.
• W3140444220 cites W3190005154 @default.
• W3140444220 cites W4205255916 @default.
• W3140444220 doi "https://doi.org/10.2215/cjn.12940820" @default.
• W3140444220 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8092055" @default.
• W3140444220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33782036" @default.
• W3140444220 hasPublicationYear "2021" @default.
• W3140444220 type Work @default.
• W3140444220 sameAs 3140444220 @default.
• W3140444220 citedByCount "4" @default.
• W3140444220 countsByYear W31404442202021 @default.
• W3140444220 countsByYear W31404442202022 @default.
• W3140444220 countsByYear W31404442202023 @default.
• W3140444220 crossrefType "journal-article" @default.
• W3140444220 hasAuthorship W3140444220A5000643733 @default.
• W3140444220 hasAuthorship W3140444220A5002432559 @default.
• W3140444220 hasAuthorship W3140444220A5007108229 @default.
• W3140444220 hasAuthorship W3140444220A5010478903 @default.
• W3140444220 hasAuthorship W3140444220A5019186356 @default.
• W3140444220 hasAuthorship W3140444220A5023335599 @default.

• next